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Abstract
Osteonecrosis after craniofacial radiation (ORN), osteomyelitis and bisphosphonates related necrosis of the jaw
(BRONJ) are the predominant bone diseases in Cranio- and Maxillofacial surgery. Although various hypothesis for
the pathophysiological mechanisms including infection, altered vascularisation or remodelling exist, the treatment
is still a challenge for clinicians. As the classical pharmacological or surgical treatment protocols have only limited
success, stem cells might be a promising treatment option, indicated by recently published data.
In maxillofacial surgery clinicians face three diseases of the
jaws predominantly: osteonecrosis after craniofacial radia-
tion (ORN), osteomyelitis and bisphosphonates related
necrosis of the jaw (BRONJ). Numerous reports exist sug-
gesting various pathological mechanisms and treatment
modalities for these diseases [1,2]. Although these publica-
tions elucidate the prevalence, risk factors and treatment
strategies, they have provided limited data on details of the
underlying pathophysiology, especially differences in the
three above mentioned diseases. The local or total immun-
supressive therapy of many patients (e.g. cancer patients)
and the universal presence of hundreds of microorganisms
in the oral cavity provide a perfect environment for
chronic infections like osteomyelitis. It is unclear if this
contributes to BROMJ too. Currently, most evidence exist
that the necrotic tissue becomes infected as opposed to
the infected tissue becomes necrotic [3]. Regarding the
effects on the immune system inconsistent data are
reported in the literature. On the one hand bisphospho-
nates inhibit T lymphocyte activation and proliferation
and suppress monocytes production of various pro-inflam-
matory cytokines [4]. On the other hand they increase the
production of pro-inflammatory cytokines by lymphocytes
[5]. Whereas the most widely accepted theory to explain
the cause of ORN is the theory of hypoxia, radio-induced
hypovascularity and hypocellularity [6,7] there is no evi-
dence that the necrotic regions in BRONJ have reduced
vasculature or blood supply. However, antiangiogenic
effects of bisphosphonates have been reported by other
authors [8]. Remoddeling suppression is an other causative
factor held responsible for BRONJ despite the fact that
there are no published data in humans showing the effects
of bisphosphonates on jaw remodeling [2]. Taken together
there are only very few studies (e.g. animal studies) clarify-
ing the basic pathophysiological mechanisms of these
bone diseases. Very recently, a new treatment modality
was introduced elucidating one possible causative factor
for BRONJ. Kikuiri and coworkers infused mesenchymal
stem cells in BRONJ-like mice. The stem cells modulated
the immune system, prevent and cure BRONJ-like disease
[9]. Since it is known, that stem cells can induce ectopic
bone formation [10] as well as angiogenesis [11], stem
cells might be a future treatment option for the above
mentioned bone diseases. Particularly, with respect to the
full capacity of various stem cell lines [12,13], these cells
might become a promising tool for clinicians.
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